Home > Qtrly Results > ERIS LIFESCIENCES

ERIS LIFESCIENCES
Quarterly Results Analysis [Sep2024]

ERIS LIFESCIENCES is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Best Quarterly Growth Small Cap Stocks
Best 1M Momentum Small Cap Stocks
COMMUNITY POLL
for ERIS LIFESCIENCES
Please provide your vote to see the results

ERIS LIFESCIENCES Quarterly Results

Consolidated Sep2024
UnAudited
Jun2024
UnAudited
Mar2024
UnAudited
Dec2023
UnAudited
Sep2023
UnAudited
Jun2023
UnAudited
Mar2023
Audited
Dec2022
UnAudited
Revenues ₹741 Cr ₹720 Cr ₹551 Cr ₹486 Cr ₹505 Cr ₹467 Cr ₹403 Cr ₹423 Cr
Expenses ₹477 Cr ₹470 Cr ₹402 Cr ₹311 Cr ₹324 Cr ₹297 Cr ₹284 Cr ₹286 Cr
Operating Income ₹265 Cr ₹250 Cr ₹148 Cr ₹176 Cr ₹181 Cr ₹170 Cr ₹119 Cr ₹137 Cr
Other Income ₹5 Cr ₹2 Cr ₹15 Cr ₹4 Cr ₹3 Cr ₹1 Cr ₹1 Cr ₹2 Cr
Interest ₹59 Cr ₹60 Cr ₹33 Cr ₹18 Cr ₹16 Cr ₹17 Cr ₹9 Cr ₹3 Cr
Depreciation ₹80 Cr ₹76 Cr ₹54 Cr ₹46 Cr ₹42 Cr ₹41 Cr ₹35 Cr ₹30 Cr
Profit Before Tax ₹129 Cr ₹115 Cr ₹77 Cr ₹116 Cr ₹126 Cr ₹112 Cr ₹76 Cr ₹107 Cr
Profit After Tax ₹96 Cr ₹89 Cr ₹80 Cr ₹101 Cr ₹122 Cr ₹94 Cr ₹61 Cr ₹100 Cr
EPS ₹6.73 ₹6.11 ₹5.22 ₹7.55 ₹9.08 ₹6.98 ₹4.81 ₹7.49
Industry Peers & Returns1W1M1Y
ERIS LIFESCIENCES 8.2% 15.1% 57.8%
SUN PHARMACEUTICAL INDUSTRIES -0.9% -4.8% 50.2%
CIPLA 1.5% 0.1% 19.9%
DR REDDYS LABORATORIES -0.4% -8.2% 7.1%
ZYDUS LIFESCIENCES 0.6% -5.3% 51%
DIVIS LABORATORIES 3% 5.9% 65%
MANKIND PHARMA 0.6% 3.1% 34.4%
TORRENT PHARMACEUTICALS 4.3% -2.7% 54.2%
LUPIN -0.1% -4.4% 72.4%

ERIS LIFESCIENCES Quarterly Revenues

Revenues
Q-o-Q

2.98 %

Y-o-Y

46.68 %

Quarters Revenues % Change
Sep2024 ₹741 Cr
2.98
Jun2024 ₹720 Cr
30.64
Mar2024 ₹551 Cr
13.29
Dec2023 ₹486 Cr
-3.76
Sep2023 ₹505 Cr
8.29
Jun2023 ₹467 Cr
15.84
Mar2023 ₹403 Cr
-4.83
Dec2022 ₹423 Cr -

ERIS LIFESCIENCES Quarterly Operating Profit

Operating Profit
Q-o-Q

5.81 %

Y-o-Y

46.03 %

Quarters Operating Profit % Change
Sep2024 ₹265 Cr
5.81
Jun2024 ₹250 Cr
68.42
Mar2024 ₹148 Cr
-15.43
Dec2023 ₹176 Cr
-3.11
Sep2023 ₹181 Cr
6.71
Jun2023 ₹170 Cr
42.77
Mar2023 ₹119 Cr
-13.34
Dec2022 ₹137 Cr -
Operating Margins
Q-o-Q

2.76 %

Y-o-Y

-0.45 %

Quarters Operating Margin% % Change
Sep2024 35.69%
2.76
Jun2024 34.73%
28.92
Mar2024 26.94%
-25.35
Dec2023 36.09%
0.67
Sep2023 35.85%
-1.46
Jun2023 36.38%
23.24
Mar2023 29.52%
-8.95
Dec2022 32.42% -

ERIS LIFESCIENCES Quarterly Profit After Tax

Profit After Tax(PAT)
Q-o-Q

7.75 %

Y-o-Y

-21.22 %

Quarters Profit After Tax % Change
Sep2024 ₹96 Cr
7.75
Jun2024 ₹89 Cr
12.29
Mar2024 ₹80 Cr
-21.51
Dec2023 ₹101 Cr
-17.04
Sep2023 ₹122 Cr
30.59
Jun2023 ₹94 Cr
52.33
Mar2023 ₹61 Cr
-38.66
Dec2022 ₹100 Cr -
PAT Margins
Q-o-Q

4.67 %

Y-o-Y

-46.28 %

Quarters PAT Margin(%) % Change
Sep2024 13 %
4.67
Jun2024 12.42 %
-14.05
Mar2024 14.45 %
-30.73
Dec2023 20.86 %
-13.80
Sep2023 24.2 %
20.58
Jun2023 20.07 %
31.52
Mar2023 15.26 %
-35.56
Dec2022 23.68 % -

ERIS LIFESCIENCES Quarterly Earnings Per Share (EPS)

EPS
Q-o-Q

10.15 %

Y-o-Y

-25.88 %

Quarters EPS % Change
Sep2024 ₹6.73
10.15
Jun2024 ₹6.11
17.05
Mar2024 ₹5.22
-30.86
Dec2023 ₹7.55
-16.85
Sep2023 ₹9.08
30.09
Jun2023 ₹6.98
45.11
Mar2023 ₹4.81
-35.78
Dec2022 ₹7.49 -

You may also like the below Video Courses